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Abstract
Background and Objectives: Rhabdomyolysis is often associated with sepsis and gram positive bacterial pathogens are
reported to be the most frequent cause of sepsis induced rhabdomyolysis. We report the pattern of infecting bacterial
pathogens and associated causal factors in a South-Indian cohort.
Design, Setting, Participants & Measurements: Retrospective cohort study of adult patients with community acquired
bacterial sepsis complicated by rhabdomyolysis from March 2003 - August 2008. Rhabdomyolysis was defined as serum
creatine kinase .2000 IU/L. The study population was divided into group-I (sepsis with gram positive pathogens), group–II
(sepsis with gram negative pathogens) and group-III (culture negative sepsis).
Results: 103 patients (group I -15, group II- 34 and group III- 54) formed the study cohort. Mean age was 55 years and two-
third had diabetes. Mean creatine kinase was 7114 IU/L and mean serum creatinine on admission was 2.4 mg/dl. Causative
pathogen of sepsis was identified in 47.5%. Gram negative pathogens were more frequently (33%) associated with
rhabdomyolysis than gram positive pathogens (14.5%). Lung was the commonest foci of sepsis (38.8%). 78.6% of the study
population had one or more additional causal factor for rhabdomyolysis like statin intake, chronic alcoholism, hypokalemia,
hypernatremia and hypophosphatemia. Mortality was 59%.
Conclusions: Gram negative bacterial pathogens were more frequently associated with rhabdomyolysis than gram positive
pathogens. Rhabdomyolysis in patients with sepsis is multifactorial and is associated with high mortality.
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Introduction
Rhabdomyolysis can be defined as disruption of skeletal muscle
leading to leakage of intracellular muscle constituents especially
myoglobin into the extracellular fluid [1]. Myoglobin is a heme
containing compound with a molecular weight of 17,400 Daltons
and may cause acute renal failure by tubular obstruction, toxicity
of heme pigments, renal ischemia and decreased glomerular
permeability [2]. Bywaters and Beal reported the first clinical
syndrome compatible with rhabdomyolysis due to crush injuries in
the year 1941 [3]. Though initially attributed to severe trauma
etiology of rhabdomyolysis now includes severe physical exertion,
drugs and toxins, muscle hypoxia, hereditary muscle enzyme
defects, metabolic and endocrine disorders, infections and
temperature alterations [4]. Acute renal failure complicates 10 to
67% cases of rhabdomyolysis and is an important cause of
mortality [5–7].
The primary clinical event in the pathogenesis of rhabdomy-
olysis is elevated creatine kinase (CK) which is often used by
clinicians to screen patients who are at risk for rhabdomyolysis.
However the extent of CK elevation which may be associated with
renal failure is not clear. Published reports have used a value of
1000 to 2500 IU/L (5 to 10 times the upper limit of normal) as a
clinically significant elevation which may predispose to acute renal
failure [8,9]. But values of CK as low as 519 IU/L have been
associated with marked elevation in serum myoglobin and biopsy
proven renal failure due to rhabdomyolysis [10].
Sepsis is an important cause of morbidity and mortality [11].
Association between sepsis and rhabdomyolysis has been shown in
multiple case reports [12–16]. But only a few original researches
are available on the spectrum of infective pathogens associated
with rhabdomyolysis [8]. This study was initiated to identify the
epidemiology and laboratory profile of rhabdomyolysis due to
bacterial sepsis in a developing nation and analyze the differences
with published literature.
Materials and Methods
Study setting and design
Retrospective cohort study of adult patients with community
acquired bacterial sepsis complicated by rhabdomyolysis from 2
tertiary care centers in South India from March 2003 to August
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e71822008. The study was approved by the Sri Ramachandra
University institutional review board. Written informed consent
was obtained from all the study patients. For patients who did not
survive when this retrospective study was conducted, a written and
informed consent was obtained from the patients nearest relative.
Sepsis was defined as systemic inflammatory response syndrome
with history or clinical examination suggestive of infection [11].
Rhabdomyolysis was defined as creatine kinase (CK) more than
2000 IU/L (10 times the upper limit of normal). The presence of
myoglobinuria was considered desirable but not mandatory for the
diagnosis of rhabdomyolysis in our study cohort since myoglobin
released after muscle injury circulates for a brief period (half life –
2 to 3 hours) and is rapidly excreted by the kidney [1] making
estimation of serum or urine myoglobin a less sensitive test for the
diagnosis of rhabdomyolysis. Patients with sepsis due to non-
bacterial causes, hospital acquired sepsis, trauma, acute coronary
syndrome, cerebrovascular accident, post-operative status, post-
cardiac arrest, hyperglycemic crisis, hypothyroidism and malig-
nant hyperthermia were not included.
Method of patient evaluation
Hospital records of consecutive patients who satisfied the entry
criteria were scrutinized for baseline characteristics (age, sex,
current smoking status, current alcohol intake, diabetes mellitus,
hypertension and current statin use), laboratory findings relevant
to rhabdomyolysis (CK, urine myoglobin, admission electrolyte
panel including calcium and phosphorus, serial serum creatinine
values, blood gases, plasma lactate and uric acid), investigations to
identify foci of sepsis (chest X-ray, ultrasound abdomen and
cultures of blood, urine, cerebrospinal fluid, etc) and final outcome
(death or survival). The study cohort was divided into 3 groups.
Group-I (sepsis with gram positive pathogens), group–II (sepsis
with gram negative pathogens) and group-III (culture negative
sepsis).
Statistical analysis
Baseline characteristics of study patients were expressed in
number (%) for discrete variables, and as mean6standard
deviation for continuous variables. Laboratory findings (CK, urine
myoglobin, serum sodium, potassium, bicarbonate, calcium and
phosphorus, serial serum creatinine values, blood gases, plasma
lactate and uric acid) in different groups were compared using one-
way analysis of variance or Kruskal Wallis analysis of variance.
Multiple comparison between groups were done using Turkey
HSD (honesty significance difference) test. A p value of ,0.05 was
considered statistically significant. All statistical analysis were done
using SPSS version 15.
Results
103 patients formed the study cohort. Baseline characteristics of
the study patients are shown in Table 1. Mean age of our study
cohort was 55 years with a predominant male distribution (60%).
47% were smokers and 41% were alcoholics. Nearly two-thirds
(64%) were suffering from diabetes mellitus and more than a third
(43%) had hypertension. 30% of our study cohort were on statins.
Among diabetic patients 35% were on statins.
The laboratory profile of the study cohort is shown in Table 2.
The mean CK was 7114 IU/L and urine myoglobin was positive
in 45%. Mean values of serum electrolytes were: sodium (Na)
2136 meq/L, potassium (K) 23.7 meq/L, bicarbonate
213.3 meq/L (was ,15 meq/l in 50%), calcium (Ca) 28.4
meq/L and phosphorus 24.5 meq/L. Mean serum creatinine on
admission was 2.4 mg/dl and progressive increase in serum
creatinine was observed in all groups. On admission the mean
arterial Ph was 7.18 (46% had ph ,7.2), mean lactate 22.8 meq/L
and mean corrected anion gap 216 meq/L. 27.2% had hypokale-
mia defined as serum potassium ,3 meq/l, 8% had hypernatremia
defined as serum sodium .150 meq/l, 2.9% had hypophosphatemia
defined as serum phosphate ,2 mg/dl. None had severe hypona-
tremia defined as serum sodium ,120 meq/l. 81 of 103 (78.6%) of
our patients had one or more additional causal factor for
rhabdomyolysis. The frequency of additional risk factor for
rhabdomyolysis in our study patients is shown in Table 3.A l l
patients received intensive care.
Analysis of variance revealed that there was no difference
between the study groups (group-I to group-III) with respect to
mean CK, frequency of myoglobinuria, admission creatinine,
dialysis day creatinine, arterial Ph, plasma lactate, serum sodium,
potassium, bicarbonate, calcium, phosphorus, uric acid and
corrected anion gap (level of significance shown in Table 2).
Table 1. Baseline characteristics of study cohort (n=103).
Variable Group-I Group-II Group –III P value
(n=15) (n=34) (n=54)
A g ei ny e a r s–m e a n 6S.D 58665 5 685 5 690 . 5
Sex
Male- no (%) 11(73) 18 (53) 33 (61) 0.39
Female- no (%) 4 (27) 16 (47) 21 (39)
Smoking- no (%) 11 (73) 11 (32) 26 (48) 0.02
Alcoholism- no (%) 5 (33) 14 (41) 23 (43) 0.8
Diabetes- no (%) 10 (67) 22 (65) 34 (63) 0.9
Hypertension–no (%) 6 (40) 16 (47) 22 (41) 0.82
Statin use -no (%) 4 (27) 11 (32) 16 (30) 0.91
Group –I: Gram positive sepsis.
Group-II: Gram negative sepsis.
Group-III: Culture negative sepsis.
doi:10.1371/journal.pone.0007182.t001
Table 2. Laboratory profile of the study cohort.
Variable Group I Group II Group III p value
Mean6S.D or no (%) (n=15) (n=34) (n=54)
CK (IU/L) 821966022 8936613109 566064131 0.18
Myoglobinuria 7 (47) 14 (41) 25 (46) 0.88
S.Na (meq/L) 13268 136671 3 7 69 0.15
S.K (meq/ 3.961.7 3.661 3.760.9 0.6
S.Bicarbonate (meq/L) 1463.6 1364.7 1364.7 0.4
S.Ca (mg/dl) 860.7 8.460.7 8.360.8 0.7
S.Phosporus (mg/dl) 4.761.1 4.261.1 4.561.1 0.34
S.Uric acid (mg/dl) 7.861.1 7.161.6 7.261.7 0.35
Anion gap (meq/L) 1662.7 15641 6 63.7 0.43
S. creatinine (mg/dl)
Admission 2.561.1 2.360.6 2.561 0.71
Dialysis day 4.261.8 5.363 5.162.8 0.47
Arterial Ph 7.1460.15 7.260.15 7.1760.14 0.52
Plasma lactate(meq/l) 2.860.6 2.860.9 2.760.8 0.86
doi:10.1371/journal.pone.0007182.t002
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test on laboratory values mentioned above showed no statistically
significant differences.
Isolated pathogens and foci of sepsis among culture positive
patients are shown in Table 4. Lung was the commonest foci
(38.8%). The cause of sepsis could be identified in 47.5% of cases.
Gram negative sepsis was more frequent (33%) than gram positive
sepsis (14.5%). All patients required dialysis. 61 of 103 (59%)
patients died.
Discussion
Infections accounted for 5% of rhabdomyolysis in the literature
25 years ago [17,18]. Betrosian et al. [8], using a strict entry
criteria for rhabdomyolysis, compared the pattern of rhabdomy-
olysis due to bacterial sepsis (n=35) with patients having sepsis
without rhabdomyolysis (n=122) and observed that infections
with gram positive pathogens (especially Staphylococcus aureus
and Streptococcus faecalis) more frequently caused rhabdomyol-
ysis than gram negative pathogens with lung being the foci of
sepsis in most patients (34%) followed by urosepsis, gall bladder
infection, pancreatitis and catheter related infections. In contrast
our study has shown the dominance of gram negative pathogens
(especially Pseudomonas, E.coli and Klebsiella) over gram positive
pathogens. Similar to their study lung was the most frequent
(38.8%) foci of sepsis in our cohort. We did not observe gall
bladder infection or pancreatitis probably due to selection bias as
these patients are predominantly managed by surgeons in our
study centers.
Further, their study [8] used a CK level more than 2500 IU/L
as definition for rhabdomyolysis and excluded patients with
acidosis defined as serum bicarbonate less than 15 meq/L in
addition to alternative causes for rhabdomyolysis (trauma, surgery,
dysnatremia, hypokalemia, hypophospatemia) since they were
attempting to correlate plasma osmolality with levels of CK. We
did not exclude patients with bicarbonate less than 15 meq/L,
dysnatremia, hypokalemia and hypophosphatemia since these
abnormalities commonly co-exist with sepsis and our objective was
to identify all contributing factors to rhabdomyolysis in patients
with sepsis. Furthermore the baseline characteristics of their study
cohort [8] with reference to co-morbidities like diabetes,
hypertension, chronic alcohol intake, concomitant statin intake is
not known. It should be noted that significant number of our
patients were suffering from diabetes (64%) and hypertension
(43%). Given this fact it is not surprising that 30% of our study
patients were on statins which can independently cause rhabdo-
myolysis. Further our patients had co-existing causal factors for
rhabdomyolysis like chronic alcoholism (41%), hypokalemia
(27.2%), hypernatremia (8%) and hypophosphatemia (2.9%).
The predominance of gram negative pathogens in our study can
be partially explained by the high proportion of diabetic patients.
The proposed mechanism of rhabdomyolysis due to sepsis are (i)
direct muscle invasion by the pathogen, (ii) toxin generation, (iii)
cytokine mediated muscle cell toxicity, and (iv) muscle ischemia
due to shock [4,17,19–23]. Rhabdomyolysis due to direct muscle
invasion and toxin generation is classical with Staphylococcus
aureus [24]. Streptococci, Salmonella and Staph. aureus have
been demonstrated in muscle biopsies of patients with rhabdomy-
olysis while Legionella, a frequent pathogen associated with
rhabdomyolysis has not been demonstrated in muscle biopsies
indicating a probable distant mechanism [4].
The mean CK and presenting biochemical investigations
between our sub-groups showed no significant differences. This
emphasizes the fact that despite different possible mechanisms
adopted by microbes the pattern of final clinical presentation of
rhabdomyolysis is similar.
The pathogens identified in our study are identical to previous
published literature except Acinetobacter which has not been
previously reported. Bacterial pathogens associated with rhabdo-
myolysis are Legionella, Streptococcus pneumoniae, Staphylococ-
cus aureus, Streptococcus viridans, Salmonella species, Staphylo-
coccus epidermidis, Francisella tularensis, Streptococcus faecalis,
Meningococci, Hemophilus influenza, E.coli, Pseudomonas,
Klebsiella, Enterococcus faecalis and Bacteroides
[4,8,10,20,25,26]. Lung was the most frequent (38.8%) foci of
sepsis in our study. This is consistent with previous reports which
show a close relation between lung sepsis and rhabdomyolysis
[8,27,28].
As discussed earlier statins, chronic alcoholism, hypokalemia,
hypernatremia and hypophosphatemia were additional causes









Table 4. Isolated pathogens and foci of sepsis among culture
positive patients (n=49).
Foci of sepsis Group I Group II
(n=15) (n=34)
Lung (n=20) S. pneumoniae: 4 P. aerogenosa: 4
S. aureus: 2 Enterobacter species: 1
S. viridans: 1 K. pneumoniae: 5
E. coli: 3
Meninges (n=10) S. aureus:1 E. coli: 2
S. pneumoniae: 2 P. aerogenosa: 3
P. mirabilis: 2




Endocardium (n=6) S. aureus: 3 E. coli: 2
S. viridans: 1
No foci (n=4) S. pneumoniae: 1 P. aerogenosa: 1
E. coli: 2
S. pneumoniae: Streptococcus pneumoniae.
S. aureus: Staphylococcus aureus.
S. viridans: Streptococcus viridans.
P. aerogenosa: Pseudomonas aerogenosa.
K. pneumoniae: Klebsiella pneumoniae.
E. coli: Escherichia coli.
P. mirabilis: Proteus mirabilis.
A. baumanni: Acinatobacter baumanni.
doi:10.1371/journal.pone.0007182.t004
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our study cohort. Combination of causal factors in patients with
rhabdomyolysis is well known [17].
Statins are supposed to induce defective glycoprotein synthesis
in muscle membrane, deficient chloride channel activation in
muscle membrane and increased intracellular calcium leading to
impaired membrane function, all leading to myocyte injury [29].
Our study cohort is notable for the high proportion of diabetics
and 35% of them were on statins. The possibility of statin intake
precipitating rhabdomyolysis in diabetic patients with sepsis
cannot be overlooked since diabetes is a known risk factor for
statin induced myopathy [30].
Rhabdomyolysis due to acute alcoholism is well known [4].
Rhabdomyolysis may also occur secondary to chronic alcohol
intake [31]. The proposed mechanism for rhabdomyolysis due to
chronic alcoholism are electrolyte disturbances like hypokalemia,
hypophosphatemia and hypomagnesemia as evidenced by marked
depletion of intracellular potassium, phosphorus and magnesium
in skeletal muscles of chronic alcoholics and experimental animals
fed with alcohol [32,33]. Potassium depletion can decrease
glycogen synthesis within muscle and also impair potassium
dependent vasodilatory response [34]. This combination of
diminished glycogen reserve and impaired oxygen delivery may
lead to ATP depletion producing muscle injury [4]. Hypophos-
phatemia may also limit ATP production and produce an energy
deficient state leading to muscle injury [4].
The mortality in our study cohort was 59%. Since our study
cohort had frequent co-morbid conditions the mortality observed
cannot be interpolated to a relatively healthy population. All our
study patients received hemodialysis probably due to the presence
of multiple disorders and progressive raise in serum creatinine
warranting aggressive management by the treating physician to
avoid unfavorable outcomes. We preferred not to analyze the
factors contributing to death since treatment of rhabdomyolysis
varied between physicians in our study. Though alkalinization of
urine and diuretics are frequently used to treat rhabdomyolysis
their efficacy in preventing progression of renal failure is unknown.
Recent evidence highlights the lack of efficacy and possible harm
with bicarbonate and diuretics [35].
Our study did not analyze the severity of illness using Acute
Physiology and Chronic Health Evaluation (APACHE) score or a
comparable score. This is an important limitation of the study
since this information would have shed more light on disease
severity on admission and during hospital stay. Since the study
primarily looked at the etiology of bacterial sepsis and not the risk
factors for poor outcome, lack of these details may not affect the
primary objective of the study.
In conclusion, our study observed that association between
rhabdomyolysis and sepsis is relatively common and is associated
with additional causal factors for rhabdomyolysis like statin use,
chronic alcohol intake, hypokalemia, hypernatremia and hypo-
phosphatemia. Lung was the most frequent septic foci and we
observed that gram negative organisms were more frequent than
gram-positive pathogens. Furthermore, our data questions the
safety of continuing statins in diabetic and alcoholic patients with
active sepsis.
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